Thermo Fisher Scientific

Plainville, MA, USA

This critical manufacturing facility has helped double Thermo Fisher’s commercial viral vector capacity. The increase in production aided the company in meeting the rising demand for developing and manufacturing gene therapies and vaccines. The estimated investment in its development was $180mm. The Plainville site includes a pilot lab that supports process development, process transfer and scale-up. It also contains 11 cGMP drug substance suites, two cGMP drug product suites and full-service quality control (QC) labs. The facility has an on-site engineering laboratory that supports clients in their efforts to advance toward commercial operations by developing turnkey production systems.

The facility also offers cell culture platforms, purification platforms, analytical assay and QC capabilities, and aseptic fill and finish services. It complements Thermo Fisher’s production capacity in Lexington and Cambridge, Massachusetts and Alachua, Florida.

Project Highlights

• Application: Fume Hood, Airflow and Temperature Control
• 300+ AccuValves^®
• Bluetooth modules used for remote connectivity for valves located in hard-to-access locations
• Model AVC, AVT and AVR AccuValves